A link between premenopausal iron deficiency and breast cancer malignancy

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Jian, Jinlong ^a   Yang, Qing ^a   Shao, Yongzhao ^a   Axelrod, Deborah ^a,b   Smith, Julia ^a,b   Singh, Baljit ^a,b   Krauter, Stephanie ^a,b   Chiriboga, Luis ^a,b   Yang, Zhaoxu ^c   Li, Jinqing ^d   Huang, Xi ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anemia; Epithelial mesenchymal transition; Hypoxia inducible factors; Iron deficiency; Metastasis; Young breast cancer

Indexed keywords

HEMOGLOBIN; IRON DEXTRAN; NOTCH RECEPTOR; PROTEIN SNAI1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; IRON;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIET; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY; IRON THERAPY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PREMENOPAUSE; PROTEIN EXPRESSION; RNA ISOLATION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; COMPLICATION; DEFICIENCY; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; IRON; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; PREMENOPAUSE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84879229020     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-307     Document Type: Article

References (33)

1. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008, 26(20):3324-3330. 10.1200/JCO.2007.14.2471, 18612148.
2. Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res 2010, 12(5):212. 10.1186/bcr2647, 3096966, 21067532.
3. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007, 9(3):R28. 10.1186/bcr1672, 1929089, 17477859.
4. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 2011, 8(11):669-676. 10.1038/nrclinonc.2011.110, 21808267.
5. Jensen EV. The contribution of "alternative approaches" to understanding steroid hormone action. Mol Endocrinol 2005, 19(6):1439-1442. 10.1210/me.2005-0154, 15914713.
6. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 2007, 357(2):115-123. 10.1056/NEJMoa070608, 17625123.
7. Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J, Guth AA. Breast cancer in young women. J Am Coll Surg 2008, 206(3):1193-1203.
8. Scrimshaw NS. Iron deficiency. Sci Am 1991, 265(4):46-52. 10.1038/scientificamerican1091-46, 1745900.
9. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007, 370(9586):511-520. 10.1016/S0140-6736(07)61235-5, 17693180.
10. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol 2009, 36(3):237-249. 10.1053/j.seminoncol.2009.03.001, 2894028, 19460581.
11. Fidler IJ, Poste G. The "seed and soil" hypothesis revisited. Lancet Oncol 2008, 9(8):808. 10.1016/S1470-2045(08)70201-8, 18672217.
12. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer 2013, 13(5):342-355. 10.1038/nrc3495, 23594855.
13. Huang X. Does iron have a role in breast cancer?. Lancet Oncol 2008, 9(8):803-807. 10.1016/S1470-2045(08)70200-6, 2577284, 18672216.
14. Collins JF, Franck CA, Kowdley KV, Ghishan FK. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am J Physiol Gastrointest Liver Physiol 2005, 288(5):G964-971. 10.1152/ajpgi.00489.2004, 15637178.
15. Yeung CK, Zhu L, Glahn RP, Miller DD. Iron absorption from NaFeEDTA is downregulated in iron-loaded rats. J Nutr 2004, 134(9):2270-2274.
16. Ali MA, Akhmedkhanov A, Zeleniuch-Jaquotte A, Toniolo P, Frenkel K, Huang X. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Cancer Detect Prev 2003, 27(2):116-121. 10.1016/S0361-090X(03)00027-8, 2965440, 12670522.
17. Yang Q, Jian J, Katz S, Abramson SB, Huang X. 17beta-estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012, 153(7):3170-3178. 10.1210/en.2011-2045, 3380311, 22535765.
18. Auerbach M, Rodgers GM. Intravenous iron. N Engl J Med 2007, 357(1):93-94. 10.1056/NEJMc070203, 17611217.
19. Jian J, Yang Q, Dai J, Eckard J, Axelrod D, Smith J, Huang X. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med 2011, 50:841-847. 10.1016/j.freeradbiomed.2010.12.028, 3046244, 21193031.
20. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011, 331(6024):1559-1564. 10.1126/science.1203543, 21436443.
21. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119(6):1420-1428. 10.1172/JCI39104, 2689101, 19487818.
22. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7(2):131-142. 10.1038/nrm1835, 16493418.
23. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9(4):265-273. 10.1038/nrc2620, 19262571.
24. Hellinger MD, Santiago CA. Reoperation for recurrent colorectal cancer. Clinics in colon and rectal surgery 2006, 19(4):228-236. 10.1055/s-2006-956445, 2780113, 20011326.
25. Vaupel P, Mayer A, Briest S, Hockel M. Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. Adv Exp Med Biol 2005, 566:333-342. 10.1007/0-387-26206-7_44, 16594170.
26. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91(12):2214-2221. 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P, 11413508.
27. Crouch Z, DeSantis ER. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review. Am J Health Syst Pharm 2009, 66(13):1180-1185. 10.2146/ajhp080214, 19535656.
28. Spivak JL, Gascon P, Ludwig H. Anemia management in oncology and hematology. Oncologist 2009, 14(Suppl 1):43-56.
29. Eckard J, Dai J, Wu J, Jian J, Yang Q, Chen H, Costa M, Frenkel K, Huang X. Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Cancer Cell Int 2010, 10(1):28. 10.1186/1475-2867-10-28, 2936284, 20723262.
30. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 2008, 105(17):6392-6397. 10.1073/pnas.0802047105, 2359811, 18427106.
31. Swain SM, Jeong JH, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010, 362(22):2053-2065. 10.1056/NEJMoa0909638, 2935316, 20519679.
32. Anonymous http://www.med.monash.edu.au/obgyn/research/menorr.html Last verified June 27, 2013, Anonymous.
33. Anonymous http://www.innvista.com/health/ailments/anemias/iron-element/ Last verified on June 27, 2013, Anonymous.